Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New research could lead to a vaccine for pneumococcus disease

23.09.2008
New research has shown how the immune system detects and destroys the bug, pneumococcus, which could help in the development of a new vaccine against the disease.

Pneumococcus is a bacterium which causes a lot of illness and disease in the very young and the elderly, including pneumonia and meningitis. Large numbers of pneumonia deaths occur in children every year especially in poor countries. Existing vaccines are not ideal for use in such countries and are also much too expensive.

Carriage of pneumococcus in the nose is a necessary first step for most infections. As children age, they carry pneumococcus for shorter periods of time and their risk of disease decreases also. The mechanisms underlying this age-related decrease of carriage are not well understood.

As part of a continuing collaboration between labs at the universities of Bristol and Harvard, researchers have shed new light on how the immune system detects and destroys the bug when it colonises the nose. The study is published in PLoS Pathogens.

American researchers led by Drs Richard Malley and Marc Lipsitch have produced evidence for a key role for the recently described cytokine interleukin 17 in a mouse model of the infection. The Bristol group led by Professor Adam Finn have shown that immune cells from children's tonsils, removed at surgery, also produce IL17 when stimulated with pneumococci.

The researchers have identified the immune cells that are responsible for this process, so-called TH17 cells, which release a factor that enables human blood cells to kill pneumococcus more efficiently. They have shown that these TH17 cells exist in adults and children, but not in newborn babies, which suggests that they may arise as a consequence of humans being exposed to pneumococcus.

Professor Finn said: "Understanding how children build up immunity to pneumococcus will help the development of effective affordable vaccines for use where they are most needed."

In the past, immunity to pneumococcus was thought to be due entirely to antibodies. This new research suggests that other mechanisms may be very important too.

Joanne Fryer | EurekAlert!
Further information:
http://www.bristol.ac.uk

Further reports about: Disease IL17 TH17 blood cell immune cell immune cells immune system pneumococci pneumococcus

More articles from Life Sciences:

nachricht Turning carbon dioxide into liquid fuel
06.08.2020 | DOE/Argonne National Laboratory

nachricht Tellurium makes the difference
06.08.2020 | Friedrich-Schiller-Universität Jena

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: ScanCut project completed: laser cutting enables more intricate plug connector designs

Scientists at the Fraunhofer Institute for Laser Technology ILT have come up with a striking new addition to contact stamping technologies in the ERDF research project ScanCut. In collaboration with industry partners from North Rhine-Westphalia, the Aachen-based team of researchers developed a hybrid manufacturing process for the laser cutting of thin-walled metal strips. This new process makes it possible to fabricate even the tiniest details of contact parts in an eco-friendly, high-precision and efficient manner.

Plug connectors are tiny and, at first glance, unremarkable – yet modern vehicles would be unable to function without them. Several thousand plug connectors...

Im Focus: New Strategy Against Osteoporosis

An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women...

Im Focus: AI & single-cell genomics

New software predicts cell fate

Traditional single-cell sequencing methods help to reveal insights about cellular differences and functions - but they do this with static snapshots only...

Im Focus: TU Graz Researchers synthesize nanoparticles tailored for special applications

“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.

Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...

Im Focus: Tailored light inspired by nature

An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.

Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“Conference on Laser Polishing – LaP 2020”: The final touches for surfaces

23.07.2020 | Event News

Conference radar for cybersecurity

21.07.2020 | Event News

Contact Tracing Apps against COVID-19: German National Academy Leopoldina hosts international virtual panel discussion

07.07.2020 | Event News

 
Latest News

Rare Earth Elements in Norwegian Fjords?

06.08.2020 | Earth Sciences

Anode material for safe batteries with a long cycle life

06.08.2020 | Power and Electrical Engineering

Turning carbon dioxide into liquid fuel

06.08.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>